Kistler-Tiffany Companies, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kistler-Tiffany Companies, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$33
-23.3%
1000.0%0.00%
Q1 2023$43
-18.9%
1000.0%0.00%
Q4 2022$531000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$01000.0%0.00%
Q1 2022$01000.0%0.00%
Q4 2021$01000.0%0.00%
Q3 2021$0
-100.0%
1000.0%0.00%
Q2 2021$1,0001000.0%0.00%
Q1 2021$01000.0%0.00%
Q4 2020$01000.0%0.00%
Q3 2020$01000.0%0.00%
Q2 2020$0
-100.0%
1000.0%0.00%
Q1 2020$1,0000.0%1000.0%0.00%
Q4 2019$1,0000.0%1000.0%0.00%
Q3 2019$1,0000.0%1000.0%0.00%
Q2 2019$1,0000.0%1000.0%0.00%
Q1 2019$1,0001000.0%0.00%
Q4 2018$0
-100.0%
1000.0%0.00%
Q3 2018$1,0000.0%1000.0%0.00%
Q2 2018$1,0000.0%1000.0%0.00%
Q1 2018$1,0000.0%1000.0%0.00%
Q4 2017$1,0000.0%1000.0%0.00%
Q3 2017$1,000
-50.0%
1000.0%0.00%
-100.0%
Q2 2017$2,0000.0%1000.0%0.00%0.0%
Q1 2017$2,0001000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders